Ratings for Inspire Medical Systems (NYSE:INSP) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $220.33, a high estimate of $285.00, and a low estimate of $170.00. Highlighting a 9.33% decrease, the current average has fallen from the previous average price target of $243.00.

Interpreting Analyst Ratings: A Closer Look

A clear picture of Inspire Medical Systems's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Inspire Medical Systems's market position. Stay informed and make well-informed decisions with our Ratings Table.

Stay up to date on Inspire Medical Systems analyst ratings.

About Inspire Medical Systems

A Deep Dive into Inspire Medical Systems's Financials

Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.

Positive Revenue Trend: Examining Inspire Medical Systems's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 28.24% as of 31 March, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: Inspire Medical Systems's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -6.1%, the company may face hurdles in effective cost management.

Return on Equity (ROE): Inspire Medical Systems's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -1.72%, the company may face hurdles in generating optimal returns for shareholders.

Return on Assets (ROA): Inspire Medical Systems's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -1.47%, the company may face hurdles in achieving optimal financial performance.

Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.04.

How Are Analyst Ratings Determined?

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.

Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

This article was generated by Benzinga's automated content engine and reviewed by an editor.